Astroglial Dysfunctions in Mood Disorders and Rodent Stress Models: Consequences on Behavior and Potential as Treatment Target.

Autor: Bansal, Yashika¹ (AUTHOR), Codeluppi, Sierra A.^1,2 (AUTHOR), Banasr, Mounira^1,2,3 (AUTHOR) mounira.banasr@camh.ca

Publikováno v: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 12, p6357. 21p.

Memantine prevents cognitive impairment and reduces Bcl-2 and caspase 8 immunoreactivity in rats injected with amyloid β1-40.

Autor: Miguel-Hidalgo JJ; Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N. State Street, Box 127, Jackson, MS 39216, USA. jmiguel-hidalgo@umc.edu, Paul IA, Wanzo V, Banerjee PK

Publikováno v: European journal of pharmacology [Eur J Pharmacol] 2012 Oct 05; Vol. 692 (1-3), pp. 38-45. Date of Electronic Publication: 2012 Jul 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Role of Caspases in Alzheimer's Disease: Pathophysiology Implications and Pharmacologic Modulation.

Autor: Khezri, Mohammad Rafi, Ghasemnejad-Berenji, Morteza

Publikováno v: Journal of Alzheimer's Disease; 2023, Vol. 91 Issue 1, p71-90, 20p

Prefrontal cortex astroglia modulate anhedonia-like behavior.

Autor: Codeluppi SA; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada., Xu M; Department of Psychiatry, Yale University, New Haven, CT, USA., Bansal Y; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada., Lepack AE; Department of Psychiatry, Yale University, New Haven, CT, USA., Duric V; Department of Psychiatry, Yale University, New Haven, CT, USA.; Department of Physiology and Pharmacology, Des Moines University, West Des Moines, IA, USA., Chow M; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada., Muir J; Integrated Program in Neuroscience, McGill University, Montréal, QC, Canada., Bagot RC; Department of Psychology, McGill University, Montreal, QC, Canada.; Ludmer Centre for Neuroinformatics and Mental Health, Montreal, QC, Canada., Licznerski P; Department of Psychiatry, Yale University, New Haven, CT, USA.; Department of Internal Medicine, Section of Endocrinology, Yale University, New Haven, CT, USA., Wilber SL; Department of Psychiatry, Yale University, New Haven, CT, USA., Sanacora G; Department of Psychiatry, Yale University, New Haven, CT, USA., Sibille E; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Duman RS; Department of Psychiatry, Yale University, New Haven, CT, USA., Pittenger C; Department of Psychiatry, Yale University, New Haven, CT, USA., Banasr M; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. mounira.banasr@camh.ca.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. mounira.banasr@camh.ca.; Department of Psychiatry, Yale University, New Haven, CT, USA. mounira.banasr@camh.ca.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. mounira.banasr@camh.ca.

Publikováno v: Molecular psychiatry [Mol Psychiatry] 2023 Nov; Vol. 28 (11), pp. 4632-4641. Date of Electronic Publication: 2023 Sep 11.